J Neurol Surg B Skull Base 2018; 79(S 04): S362-S370
DOI: 10.1055/s-0038-1668540
WFSBS 2016
Georg Thieme Verlag KG Stuttgart · New York

The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas

Roy Thomas Daniel
1   Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, VauD, Switzerland
2   Faculty of Biology and Medicine, University of Lausanne, Lausanne, VauD, Switzerland
,
Constantin Tuleasca
1   Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, VauD, Switzerland
2   Faculty of Biology and Medicine, University of Lausanne, Lausanne, VauD, Switzerland
3   Medical Image Analysis Laboratory (MIAL), Lausanne University Hospital, Lausanne, VauD, Switzerland
4   Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne, Lausanne, VauD, Switzerland
,
Alda Rocca
1   Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, VauD, Switzerland
,
Mercy George
2   Faculty of Biology and Medicine, University of Lausanne, Lausanne, VauD, Switzerland
5   Department of Otorhinolaryngology/Head & Neck Surgery, Lausanne University Hospital, Lausanne, VauD, Switzerland
,
Etienne Pralong
1   Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, VauD, Switzerland
2   Faculty of Biology and Medicine, University of Lausanne, Lausanne, VauD, Switzerland
,
Luis Schiappacasse
2   Faculty of Biology and Medicine, University of Lausanne, Lausanne, VauD, Switzerland
6   Radiation Oncology Service, Lausanne, VauD, Switzerland
,
Michele Zeverino
2   Faculty of Biology and Medicine, University of Lausanne, Lausanne, VauD, Switzerland
7   Institute of Radiation Physics, Lausanne University Hospital (CHUV), Lausanne, VauD, Switzerland
,
Raphael Maire
2   Faculty of Biology and Medicine, University of Lausanne, Lausanne, VauD, Switzerland
5   Department of Otorhinolaryngology/Head & Neck Surgery, Lausanne University Hospital, Lausanne, VauD, Switzerland
,
Mahmoud Messerer
1   Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, VauD, Switzerland
2   Faculty of Biology and Medicine, University of Lausanne, Lausanne, VauD, Switzerland
,
Marc Levivier
1   Department of Clinical Neurosciences, Neurosurgery Service and Gamma Knife Center, Lausanne University Hospital, Lausanne, VauD, Switzerland
2   Faculty of Biology and Medicine, University of Lausanne, Lausanne, VauD, Switzerland
› Author Affiliations
Further Information

Publication History

01 February 2018

11 July 2018

Publication Date:
23 August 2018 (online)

Preview

Abstract

Objective Planned subtotal resection followed by Gamma Knife surgery (GKS) in patients with large vestibular schwannoma (VS) has emerged during the past decade, with the aim of a better functional outcome for facial and cochlear function.

Methods We prospectively collected patient data, surgical, and dosimetric parameters of a consecutive series of patients treated by this method at Lausanne University Hospital during the past 8 years.

Results A consecutive series of 47 patients were treated between July 2010 and January 2018. The mean follow-up after surgery was 37.5 months (median: 36, range: 0.5–96). Mean presurgical tumor volume was 11.8 mL (1.47–34.9). Postoperative status showed normal facial nerve function (House–Brackmann I) in all patients. In a subgroup of 28 patients, with serviceable hearing before surgery and in which cochlear nerve preservation was attempted at surgery, 26 (92.8%) retained serviceable hearing. Nineteen had good or excellent hearing (Gardner–Robertson class 1) before surgery, and 16 (84.2%) retained it after surgery. Mean duration between surgery and GKS was 6 months (median: 5, range: 3–13.9). Mean residual volume as compared with the preoperative one at GKS was 31%. Mean marginal dose was 12 Gy (11–12). Mean follow-up after GKS was 34.4 months (6–84).

Conclusion Our data show excellent results in large VS management with a combined approach of microsurgical subtotal resection and GKS on the residual tumor, with regard to the functional outcome and tumor control. Longer term follow-up is necessary to fully evaluate this approach, especially regarding tumor control.